Abeona Therapeutics Inc. | Key People and Executives
Steve H. Rouhandeh
Executive Chairman
Timothy J. Miller
President, Chief Scientific Officer & Director
Richard Van Dyune
Independent Director
Stefano Buono
Independent Director
Todd Wider
Independent Director
Mark J. Alvino
Independent Director
Stephen B. Howell
Independent Director
Steve H. Rouhandeh
Executive Chairman
Timothy J. Miller
President, Chief Scientific Officer & Director
Jeffrey Davis
Chief Operating Officer
Stephen B. Thompson
Secretary, Treasurer & Vice President-Finance
Astrid Paneda Rodriguez
Vice President-Clinical Development
Juan Ruiz
Chief Medical Officer
Jay Bircher
Vice President-Quality & Compliance
Max Colao
Chief Commercial Officer
Christine Berni-Silverstein
Vice President-Finance & Investor Relations
Kristina Maximenko
Vice-President & Head-Human Resources
Kaye Spratt
Vice President-Regulatory & Quality Assurance
Richard Van Dyune
Independent Director
Stefano Buono
Independent Director
Todd Wider
Independent Director
Mark J. Alvino
Independent Director
Stephen B. Howell
Independent Director
| Address |
1330 Avenue of the Americas
New York New York 10019
United States
|
|
Employees
|
- |
| Website |
http://www.abeonatherapeutics.com |
| Updated |
07/08/2019 |
| Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB); ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA) and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in Dallas, TX. |
